Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ) rocketted at $4.03, a gain of 14.5%. On Thu, Jul 29, 2021, BCLI:NASDAQ hit a New 2-Week Intraday High of $3.63. The stock got featured on our News Catalysts scanner on Tue, Jul 27, 2021 at 07:18 AM in the 'PRIVATE PLACEMENT' category. From Thu, Jul 15, 2021, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Thu, Feb 04, 2021 at $8.14 with a volume of 4M+, and its share price has been moving sideways in recent weeks.
About Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ)
Brainstorm Cell Therapeutics Inc is a biotechnology company. The Company develops novel adult stem cell therapies for debilitating neurodegenerative disorders such as ALS, MS, and PD among others.
Top 10 Gainers:
- ERYTECH Pharma S.A. (ERYP:NASDAQ), 54.99%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 38.89%
- Marin Software Incorporated (MRIN:NASDAQ), 28.17%
- Atlassian Corporation Plc (TEAM:NASDAQ), 21.86%
- iFresh Inc. (IFMK:NASDAQ), 21.62%
- RLYB (RLYB:NASDAQ), 20.57%
- SNTG (SNTG:NASDAQ), 17.27%
- Silicon Motion Technology Corporation (SIMO:NASDAQ), 16.63%
- Alpha Pro Tech, Ltd. (APT:NYSEMKT), 15.37%
- Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ), 14.49%